Jin Medical International Ltd.
ZJYL
$1.85
-$0.13-6.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.53% | -16.53% | -6.40% | -6.40% | 35.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.53% | -16.53% | -6.40% | -6.40% | 35.29% |
| Cost of Revenue | -0.51% | -0.51% | 8.71% | 8.71% | 14.37% |
| Gross Profit | -36.18% | -36.18% | -33.30% | -33.30% | 74.44% |
| SG&A Expenses | -31.85% | -31.85% | 15.73% | 15.73% | 98.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 46.75% | 46.75% | 113.77% | 113.77% | -40.92% |
| Total Operating Expenses | -7.52% | -7.52% | 10.81% | 10.81% | 24.35% |
| Operating Income | -55.91% | -55.91% | -136.95% | -136.95% | 119.89% |
| Income Before Tax | -27.79% | -27.79% | -98.58% | -98.58% | 73.41% |
| Income Tax Expenses | -57.12% | -57.12% | -93.66% | -93.66% | 225.79% |
| Earnings from Continuing Operations | -20.01% | -20.01% | -99.47% | -99.47% | 54.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -155.29% | -155.29% | -209.13% | -209.13% | -- |
| Net Income | -31.96% | -31.96% | -104.96% | -104.96% | 69.26% |
| EBIT | -55.91% | -55.91% | -136.95% | -136.95% | 119.89% |
| EBITDA | -53.52% | -53.52% | -123.94% | -123.94% | 109.34% |
| EPS Basic | -31.95% | -31.95% | -104.97% | -104.97% | 67.64% |
| Normalized Basic EPS | -41.73% | -41.73% | -105.92% | -105.92% | 93.06% |
| EPS Diluted | -31.95% | -31.95% | -104.97% | -104.97% | 67.64% |
| Normalized Diluted EPS | -41.73% | -41.73% | -105.92% | -105.92% | 93.06% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.09% | 0.09% | 0.96% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.09% | 0.09% | 0.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |